Skip to main content
Clinical Trials/ISRCTN17418767
ISRCTN17418767CompletedNot Applicable

Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in the Sultanate of Oma

World Health Organization (WHO) (Switzerland)0 sites400 target enrollmentStarted: August 15, 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
400

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Healthy Omani newborns (greater than 2.5 kg, apgar score greater than 9 at five minutes)
  • 2. Living within the catchment area of the participating study site
  • 3. Newborns delivered by caesarean section

Exclusion Criteria

  • 1. Newborns requiring hospitalisation (except if in hospital because of maternal admission)
  • 2. Birth weight below 2.5 kg
  • 3. Apgar score less than 9 at five minutes
  • 4. Non-Omani
  • 5. Residence outside the catchment area, or families expecting to move away during the study period
  • 6. A diagnosis or suspicion of immunodeficiency disorder (either in the participant or in a member of the immediate family) will also render the newborn ineligible for the study

Investigators

Sponsor
World Health Organization (WHO) (Switzerland)

Similar Trials